PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.740
-1.410 (-27.38%)
At close: Jul 21, 2026, 4:00 PM EDT
3.700
-0.040 (-1.07%)
After-hours: Jul 21, 2026, 7:59 PM EDT
PolyPid Employees
As of December 31, 2025, PolyPid had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees increased by 14 or 22.95% compared to the previous year.
Employees
75
Change (1Y)
14
Growth (1Y)
22.95%
Revenue / Employee
n/a
Profits / Employee
-$448,387
Market Cap
71.71M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 14 | 22.95% | 69 | 6 |
| Dec 31, 2024 | 61 | -1 | -1.61% | 57 | 4 |
| Dec 31, 2023 | 62 | 2 | 3.33% | 59 | 3 |
| Dec 31, 2022 | 60 | -19 | -24.05% | 57 | 3 |
| Dec 31, 2021 | 79 | 10 | 14.49% | 75 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Adicet Bio | 102 |
| Rani Therapeutics Holdings | 71 |
| Spero Therapeutics | 25 |
| NeurAxis | 24 |
| Cognition Therapeutics | 14 |
| MAIA Biotechnology | 13 |
| Rein Therapeutics | 10 |
PYPD News
- 13 hours ago - Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue - TheFly
- 19 hours ago - PolyPid Stock (PYPD) Plummets Despite Deal With Azurity to Tackle Surgical Infections - TipRanks
- 20 hours ago - PolyPid enters exclusive pact with Azurity Pharmaceuticals for D-PLEX100 - TheFly
- 20 hours ago - PolyPid, Azurity sign surgical site infection drug deal - Reuters
- 20 hours ago - PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada - GlobeNewsWire
- 7 weeks ago - PolyPid completes NDA submission to FDA for D-PLEX100 - TheFly
- 7 weeks ago - PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ - GlobeNewsWire
- 7 weeks ago - PolyPid Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts